Torsten O Nielsen

Torsten O Nielsen

UNVERIFIED PROFILE

Are you Torsten O Nielsen?   Register this Author

Register author
Torsten O Nielsen

Torsten O Nielsen

Publications by authors named "Torsten O Nielsen"

Are you Torsten O Nielsen?   Register this Author

100Publications

3395Reads

33Profile Views

Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort.

Breast Cancer Res Treat 2019 Sep 14. Epub 2019 Sep 14.

Genetic Pathology Evaluation Centre and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05438-yDOI Listing
September 2019

The FUS-DDIT3 Interactome in Myxoid Liposarcoma.

Neoplasia 2019 Aug 17;21(8):740-751. Epub 2019 Jun 17.

Department of Pathology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2019.05.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584455PMC
August 2019

Detection of CSF1 rearrangements deleting the 3' UTR in tenosynovial giant cell tumors.

Genes Chromosomes Cancer 2019 Aug 30. Epub 2019 Aug 30.

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22807DOI Listing
August 2019

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas.

Mod Pathol 2019 Jul 1. Epub 2019 Jul 1.

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0312-yDOI Listing
July 2019

Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial.

Int J Cancer 2019 05 6;144(10):2578-2586. Epub 2018 Dec 6.

Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31969
Publisher Site
http://dx.doi.org/10.1002/ijc.31969DOI Listing
May 2019

Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study.

Lab Invest 2019 01 4;99(1):107-117. Epub 2018 Sep 4.

Department of Pathology, Yale School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41374-018-0123-7DOI Listing
January 2019

Indoleamine Dioxygenase Inhibitors: Clinical Rationale and Current Development.

Curr Oncol Rep 2019 01 18;21(1). Epub 2019 Jan 18.

Genetic Pathology Evaluation Centre, Department of Pathology & Laboratory Medicine, University of British Columbia, 509-3660 Oak St, Vancouver, BC, V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-019-0750-1
Publisher Site
http://dx.doi.org/10.1007/s11912-019-0750-1DOI Listing
January 2019

Emerging targets in cancer immunotherapy.

Semin Cancer Biol 2018 10 5;52(Pt 2):39-52. Epub 2017 Oct 5.

Department of Pathology & Laboratory Medicine, University of British Columbia Hospital, Koerner Pavilion, #G-227 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2017.10.001DOI Listing
October 2018

TIM-3 expression in breast cancer.

Oncoimmunology 2018 23;7(11):e1502128. Epub 2018 Aug 23.

Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2018.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2018.1502128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205019PMC
August 2018

PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer.

J Clin Oncol 2018 03 25;36(8):735-740. Epub 2018 Jan 25.

Anne-Vibeke Lænkholm, Jens Ole Eriksen, and Torben Kibøl, Zealand University Hospital, Slagelse; Maj-Britt Jensen, Ann S. Knoop, Maj-Lis Møller Talman, and Bent Ejlertsen, Rigshospitalet, Copenhagen; Birgitte Bruun Rasmussen, Herlev Hospital, Herlev; Anne Marie Bak Jylling, Odense University Hospital, Odense; Tomasz Piotr Tabor, Vejle Hospital, Vejle, Denmark; Wesley Buckingham, Sean Ferree, Carl Schaper, and Taryn Haffner, NanoString Technologies, Seattle, WA; and Torsten O. Nielsen, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.6586DOI Listing
March 2018

The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.

Cancer Cell 2018 03 1;33(3):527-541.e8. Epub 2018 Mar 1.

Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.01.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881394PMC
March 2018

Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.

Breast Cancer Res Treat 2018 Feb 20;168(1):107-115. Epub 2017 Nov 20.

Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, 509-2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4583-z
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4583-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823734PMC
February 2018

Development and Evaluation of a Pan-Sarcoma Fusion Gene Detection Assay Using the NanoString nCounter Platform.

J Mol Diagn 2018 01 20;20(1):63-77. Epub 2017 Nov 20.

Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Department of Pathology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15251578173031
Publisher Site
http://dx.doi.org/10.1016/j.jmoldx.2017.09.007DOI Listing
January 2018

Mortality and recurrence rates among systemically untreated high risk breast cancer patients included in the DBCG 77 trials.

Acta Oncol 2018 Jan 23;57(1):135-140. Epub 2017 Nov 23.

a Danish Breast Cancer Cooperative Group (DBCG) , Secretariat and Statistical Office, Rigshospitalet, Copenhagen University Hospital , Copenhagen , Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0284186X.2017.1400181DOI Listing
January 2018

Death by HDAC Inhibition in Synovial Sarcoma Cells.

Mol Cancer Ther 2017 Dec 6;16(12):2656-2667. Epub 2017 Sep 6.

Faculty of Medicine, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-0397DOI Listing
December 2017

HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma.

PLoS One 2017 5;12(1):e0169407. Epub 2017 Jan 5.

Faculty of Medicine, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0169407PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215898PMC
August 2017

Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer.

Clin Breast Cancer 2017 07 20;17(4):e215-e224. Epub 2017 Jan 20.

Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.01.002DOI Listing
July 2017

Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.

Breast Cancer 2017 Jan 2;24(1):3-15. Epub 2016 May 2.

Pathology and Laboratory Medicine, Anatomical Pathology JPN 1401, University of British Columbia, 855 W. 12th Avenue, Vancouver, BC, V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-016-0698-zDOI Listing
January 2017

Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.

Histopathology 2017 Jan 29;70(2):185-194. Epub 2016 Sep 29.

Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13038DOI Listing
January 2017

Advances in sarcoma diagnostics and treatment.

Oncotarget 2017 Jan;8(4):7068-7093

Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351692PMC
January 2017

Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.

Breast Cancer Res Treat 2016 Feb 4;155(3):483-90. Epub 2016 Feb 4.

Department of Laboratory Medicine and Pathology, University of British Columbia, 899 W 12th Ave, Vancouver, BC, V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3689-zDOI Listing
February 2016

The genomic landscape of epithelioid sarcoma cell lines and tumours.

J Pathol 2016 Jan 19;238(1):63-73. Epub 2015 Oct 19.

Genetic Pathology Evaluation Centre, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4636DOI Listing
January 2016

New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.

Clin Cancer Res 2015 Nov 1;21(21):4753-9. Epub 2015 Sep 1.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0831DOI Listing
November 2015

Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy.

J Clin Oncol 2015 Jun 11;33(18):2035-40. Epub 2015 May 11.

Fei-Fei Liu, Anthony W. Fyles, Wei Shi, Susan J. Done, Naomi Miller, Melania Pintilie, and David R. McCready, Princess Margaret Cancer Centre/University Health Network; Sharon Nofech-Mozes, Sunnybrook Odette Cancer Center; Martin C. Chang, Mt. Sinai Hospital, University of Toronto, Toronto; Timothy J. Whelan, Juravinski Cancer Centre, McMaster University, Hamilton, ON; David Voduc, Torsten O. Nielsen, and Lorna M. Weir, British Columbia Cancer Agency, Vancouver; and Ivo A. Olivotto, British Columbia Cancer Agency, Victoria, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.7999DOI Listing
June 2015

Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Oncologist 2015 May 23;20(5):474-82. Epub 2015 Apr 23.

Lineberger Comprehensive Cancer Center and Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA; Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, United Kingdom; Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Translation Genomics Unit, Vall d´Hebron Institute of Oncology, Barcelona, Spain; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Oncology, Hospital General Universitario de Elche, Alicante, Spain; Department of Medical Oncology, Instituto Valenciano de Oncologia, Valencia, Spain; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, Coruña, Spain; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain; GEICAM, Madrid, Spain; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada; Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA; Department of Medicine, Washington University, St. Louis, Missouri, USA; Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425383PMC
May 2015

NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.

Mod Pathol 2015 Apr 21;28(4):587-95. Epub 2014 Nov 21.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2014.155DOI Listing
April 2015

Cancer genomics: why rare is valuable.

J Mol Med (Berl) 2015 Apr 14;93(4):369-81. Epub 2015 Feb 14.

Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-015-1260-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366545PMC
April 2015

CCR 20th Anniversary Commentary: The Development of Breast Cancer Molecular Subtyping.

Clin Cancer Res 2015 Apr;21(8):1779-81

Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2552DOI Listing
April 2015

Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.

Cancer Discov 2015 Feb 22;5(2):124-34. Epub 2015 Jan 22.

Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-1246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320664PMC
February 2015

Developing a new generation of breast cancer clinical gene expression tests.

Breast Cancer Res 2014 Jul 7;16(4):103. Epub 2014 Jul 7.

Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, 2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100317PMC
July 2014

PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients.

Acta Oncol 2014 Jun 20;53(6):776-87. Epub 2013 Dec 20.

Department of Pathology, Herlev University Hospital , Herlev , Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/0284186X.2013.865076DOI Listing
June 2014

Diagnostic value of next-generation sequencing in an unusual sphenoid tumor.

Oncologist 2014 Jun 7;19(6):623-30. Epub 2014 May 7.

Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada; Division of Oncology/Hematology/BMT, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada; Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0390DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041668PMC
June 2014

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.

Clin Cancer Res 2014 Mar 11;20(5):1298-305. Epub 2014 Feb 11.

Authors' Affiliations: Departments of Medicine I, Pathology, and Surgery; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna; Austrian Breast and Colorectal Cancer Study Group, Vienna; Departments of Internal Medicine III and Pathology, Paracelsus Private Medical University, Salzburg; Departments of Internal Medicine and Pathology, Medical University of Graz, Graz; Departments of Pathology and Surgery, Sisters of Charity Hospital and Cancer Center, Linz; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck; Department of Surgery, General Hospital Baden, Baden, Austria; Myraqa, Redwood Shores, California; NanoString Technologies, Seattle, Washington; and British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1845DOI Listing
March 2014

Activating transcription factor 2 in mesenchymal tumors.

Hum Pathol 2014 Feb 27;45(2):276-84. Epub 2013 Nov 27.

Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, British Columbia, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2013.09.003DOI Listing
February 2014

An international Ki67 reproducibility study.

J Natl Cancer Inst 2013 Dec 7;105(24):1897-906. Epub 2013 Nov 7.

Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888090PMC
December 2013

A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.

Mod Pathol 2013 Nov 24;26(11):1438-50. Epub 2013 May 24.

1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.97DOI Listing
November 2013

Myxoid liposarcoma in a 91-year-old patient.

Mol Cytogenet 2013 Nov 19;6(1):50. Epub 2013 Nov 19.

Department of pathology and laboratory medicine, University of British Columbia, 899 West 12th Avenue, Vancouver, British Columbia V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1755-8166-6-50DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843574PMC
November 2013

Reply to Y.Yamamoto et al.

J Clin Oncol 2013 Jul;31(19):2517-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.9061DOI Listing
July 2013

YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.

Hum Pathol 2013 May 15;44(5):837-43. Epub 2012 Nov 15.

Department of Pathology and Laboratory Medicine, and Genetic Pathology Evaluation Center, Vancouver General Hospital, Vancouver, British Columbia, Canada V5Z 4E3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2012.08.007DOI Listing
May 2013

Sox10 and S100 in the diagnosis of soft-tissue neoplasms.

Appl Immunohistochem Mol Morphol 2012 Oct;20(5):445-50

Department of Pathology, Stanford University Medical Center, Palo Alto, CA 94025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e318244ff4bDOI Listing
October 2012

Pazopanib for metastatic soft-tissue sarcoma.

Lancet 2012 Sep;380(9844):801; author reply 801

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(12)61440-8DOI Listing
September 2012

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.

Breast Cancer Res 2012 Mar 15;14(2):R48. Epub 2012 Mar 15.

Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, 2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446382PMC
March 2012

Histone deacetylase 1 and 2 in mesenchymal tumors.

Mod Pathol 2012 Feb 28;25(2):222-30. Epub 2011 Oct 28.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2011.157DOI Listing
February 2012

Low-grade fibromyxoid sarcoma of the perineum with heterotopic ossification: case report and review of the literature.

Hum Pathol 2011 Nov 11;42(11):1804-9. Epub 2011 Jun 11.

Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia V5Z1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2011.01.023DOI Listing
November 2011

Kaposi sarcoma of the adrenal gland resembling epithelioid angiosarcoma: a case report.

Sarcoma 2011 9;2011:898257. Epub 2011 Aug 9.

Anatomical Pathology JP1401, Vancouver Hospital, 855 West 12th Avenue, Vancouver, BC, V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/898257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153921PMC
November 2011

Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.

Sci Transl Med 2011 Nov;3(108):108ra113

Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3002564DOI Listing
November 2011

Synergism of heat shock protein 90 and histone deacetylase inhibitors in synovial sarcoma.

Sarcoma 2009 24;2009:794901. Epub 2009 Mar 24.

Jack Bell Research Centre, Vancouver Coastal Health Research Institute, The University of British Columbia, 553 - 2660 Oak Street, Vancouver, BC, Canada V6H3Z6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2009/794901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659882PMC
July 2011

Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor.

Sarcoma 2010 13;2010:174528. Epub 2010 Oct 13.

Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada V5Z 1M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2010/174528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957133PMC
July 2011

Discovery research to clinical trial: a ten year journey.

Clin Invest Med 2010 Dec 1;33(6):E342-8. Epub 2010 Dec 1.

Anatomical Pathology, Vancouver Hospital & Health Sciences Ctr., 855 West 12th Avenue, Vancouver, British Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.25011/cim.v33i6.14584DOI Listing
December 2010

Metastatic behavior of breast cancer subtypes.

J Clin Oncol 2010 Jul 24;28(20):3271-7. Epub 2010 May 24.

Vancouver Clinic, Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.9820DOI Listing
July 2010

Biomarkers for Basal-like Breast Cancer.

Cancers (Basel) 2010 May 28;2(2):1040-65. Epub 2010 May 28.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers2021040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835118PMC
May 2010

Translating gene expression into clinical care: sarcomas as a paradigm.

J Clin Oncol 2010 Apr 1;28(10):1796-805. Epub 2010 Mar 1.

Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.1917DOI Listing
April 2010

Breast cancer subtypes and the risk of local and regional relapse.

J Clin Oncol 2010 Apr 1;28(10):1684-91. Epub 2010 Mar 1.

Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.24.9284DOI Listing
April 2010

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.

Breast Cancer Res Treat 2010 Jan 10;119(1):53-61. Epub 2009 Feb 10.

Genetic Pathology Evaluation Centre at Vancouver General Hospital, Prostate Center, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0318-0DOI Listing
January 2010

Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.

Am J Surg Pathol 2009 Dec;33(12):1743-51

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181b7ed36DOI Listing
December 2009

HER2 Intermediate Breast Cancers.

Am J Surg Pathol 2009 Nov;33(11):1739; author reply 1739-40

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181b72865DOI Listing
November 2009

Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.

Hum Pathol 2009 Sep 14;40(9):1244-51. Epub 2009 Apr 14.

Vancouver Coastal Health Research Institute and University of British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2009.01.011DOI Listing
September 2009

Expression of insulin-like growth factor 2 in mesenchymal neoplasms.

Mod Pathol 2009 Jul 1;22(7):914-21. Epub 2009 May 1.

Department of Pathology, University Hospital of Northern Norway and University of Tromsø, Tromsø, Norway.

View Article

Download full-text PDF

Source
https://www.mcgill.ca/pollak-lab/files/pollak-lab/expression
Web Search
http://www.nature.com/doifinder/10.1038/modpathol.2009.48
Publisher Site
http://dx.doi.org/10.1038/modpathol.2009.48DOI Listing
July 2009

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

J Natl Cancer Inst 2009 May 12;101(10):736-50. Epub 2009 May 12.

Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djp082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684553PMC
May 2009